Literature DB >> 22894968

Pentavalent vaccine: a major breakthrough in India's Universal Immunization Program.

Mohan Bairwa1, Manju Pilania, Meena Rajput, Pardeep Khanna, Neelam Kumar, Mukesh Nagar, Sumit Chawla.   

Abstract

Immunization is one of the most important public health interventions and a cost effective strategy to control the infectious diseases especially in children. Complete immunization coverage in India has increased from below 20% in the 1980s to nearly 61% at present, but still more than 1/3rd children remain un-immunized. Advent of combination vaccines has facilitated incorporation of additional vaccines into immunization schedule. Pentavalent vaccine, against five killer diseases-diphtheria, pertussis, tetanus, hepatitis B and Hemophilus influenza type B (Hib), has been introduced in almost all GAVI eligible countries by 2011. Government of India introduced the vaccine in two states in pilot phase and has given green signal to six more states. The use of pentavalent vaccine automatically raises the coverage level of hepatitis B and Hib vaccines. If the vaccines are provided individually, the coverage of hepatitis B and Hib vaccines usually lags behind DPT coverage. This gap can be filled by using pentavalent vaccine in routine immunization programmes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22894968      PMCID: PMC3579914          DOI: 10.4161/hv.20651

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  19 in total

1.  Nasopharyngeal carriage of Haemophilus influenzae.

Authors:  B K Das; N K Arora; P Mathur; P Ostwal; S Mandal; S K Kabra; A Kapil; M K Lalitha; K Thomas
Journal:  Indian J Pediatr       Date:  2002-09       Impact factor: 1.967

2.  NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India.

Authors: 
Journal:  Indian Pediatr       Date:  2009-11       Impact factor: 1.411

3.  Diagnosis and outcome of acute bacterial meningitis in early childhood.

Authors:  Nandita Chinchankar; Meenakshi Mane; Sheila Bhave; Swatee Bapat; Ashish Bavdekar; Anand Pandit; K B Niphadkar; Anil Dutta; Didier Leboulleux
Journal:  Indian Pediatr       Date:  2002-10       Impact factor: 1.411

4.  Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.

Authors:  Hitt J Sharma; Sangita Yadav; Sanjay K Lalwani; Subhash V Kapre; Suresh S Jadhav; Anita Chakravarty; Sameer S Parekh; Sonali Palkar; Subodh H Bhardwaj; Gajanan S Namjoshi; Vikas Verma
Journal:  Hum Vaccin       Date:  2011-04-01

5.  The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule.

Authors:  Sukanta Chatterjee; Sylvan J Rego; Fulton D'Souza; B D Bhatia; Alix Collard; Sanjoy K Datta; Jeanne-Marie Jacquet
Journal:  BMC Infect Dis       Date:  2010-10-15       Impact factor: 3.090

6.  Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants.

Authors:  S B Bavdekar; P P Maiya; S D Subba Rao; S K Datta; H L Bock
Journal:  Indian Pediatr       Date:  2007-07       Impact factor: 1.411

Review 7.  Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.

Authors:  James P Watt; Lara J Wolfson; Katherine L O'Brien; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Orin S Levine; Rana Hajjeh; Kim Mulholland; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

8.  A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (liq) and TritanrixHB + Hiberix (lyo) in Indian infants administered according to the EPI schedule.

Authors:  Raman Rao; Mandeep S Dhingra; Sandeep Bavdekar; Narendra Behera; Subhash R Daga; Ashok K Dutta; Ritabrata Kundu; Padmanabha Maiya; Pravakar Mishra; Raju Shah; Sankaranarayan Shuba; Vinoo Tibrewala; Shaloo Pandhi; Arul Mani Rajamani
Journal:  Hum Vaccin       Date:  2009-06-12

9.  Predictors of long term neurological outcome in bacterial meningitis.

Authors:  Pratibha Singhi; Arun Bansal; P Geeta; Sunit Singhi
Journal:  Indian J Pediatr       Date:  2007-04       Impact factor: 5.319

10.  Increasing the demand for childhood vaccination in developing countries: a systematic review.

Authors:  Beverley Shea; Neil Andersson; David Henry
Journal:  BMC Int Health Hum Rights       Date:  2009-10-14
View more
  4 in total

1.  Study on the effectiveness and impact of pentavalent vaccination program in India and other south Asian countries.

Authors:  Sreelakshmi Sreedhar; Anil Antony; Neethu Poulose
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Implications of private sector Hib vaccine coverage for the introduction of public sector Hib-containing pentavalent vaccine in India: evidence from retrospective time series data.

Authors:  Abhishek Sharma; Warren A Kaplan; Maulik Chokshi; Habib Hasan Farooqui; Sanjay P Zodpey
Journal:  BMJ Open       Date:  2015-02-23       Impact factor: 2.692

Review 3.  Coinfections and comorbidities in African health systems: At the interface of infectious and noninfectious diseases.

Authors:  Derick Nii Mensah Osakunor; David Moinina Sengeh; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2018-09-20

4.  Addressing the social issues around vaccination could be the pivotal strategy to achieve the 2022 COVID-19 vaccination coverage target.

Authors:  Gabriel Omoniyi Ayeni; Israel Oluwaseyidayo Idris; Yusuff Adebayo Adebisi
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.